BioAge is translating insights from the science of aging into new medicines Podcast Por  arte de portada

BioAge is translating insights from the science of aging into new medicines

BioAge is translating insights from the science of aging into new medicines

Escúchala gratis

Ver detalles del espectáculo
OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.

Scott Neidhold, Director in RBC’s Life Sciences Investment Banking Practice, sits down with Kristen Fortney, CEO and Co-Founder of BioAge, for a deep dive into how her company is turning cutting-edge aging science into real therapeutic breakthroughs — and what it means for the future of biopharma.

Todavía no hay opiniones